Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia

Por Šimkovič, Martin, Motyčková, Monika, Belada, David, Vodárek, Pavel, Kapoor, Rahul, Jaffar, Hamna, Vrbacký, Filip, Žák, Pavel, Smolej, Lukáš
Publicado no Arch Med Sci (2015)